Ronald K. Lloyd - 08 Mar 2022 Form 4 Insider Report for AZIYO BIOLOGICS, INC. (ELUT)

Reporting relationship: PRESIDENT AND CEO, Director
Issuer ticker: ELUT
Reported as of: 08 Mar 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Mar 2022, 19:39:12 UTC
Prior SEC filing: 11 May 2021
Source filing: View source filing
Reporting owner signature: /s/ Jeffrey Hamet, Attorney-in-Fact for Ronald K. Lloyd

Key filing fact

Ronald K. Lloyd filed Form 4 for AZIYO BIOLOGICS, INC. (ELUT) on 10 Mar 2022.

Key facts

This page summarizes Ronald K. Lloyd's Form 4 filing for AZIYO BIOLOGICS, INC. (ELUT).
5 reported transactions and 4 derivative rows are listed below.
Accepted by SEC: 10 Mar 2022, 19:39.

Change

Previous filing in this sequence was filed on 11 May 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AZYO transaction

Class A Common Stock

Options Exercise

Transaction value: $0
Shares: +4,072
Change %: +15%
Price: $0.000000
Shares after: 31,775
Date: 08 Mar 2022
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AZYO transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +138,770
Change %
Price: $0.000000
Shares after: 138,770
Date: 08 Mar 2022
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 138,770
Exercise price: $5.08
Footnotes: F3

AZYO transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +37,788
Change %
Price: $0.000000
Shares after: 37,788
Date: 08 Mar 2022
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 37,788
Exercise price
Footnotes: F4, F5

AZYO transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -4,072
Change %: -25%
Price: $0.000000
Shares after: 12,216
Date: 08 Mar 2022
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 4,072
Exercise price
Footnotes: F1, F6

AZYO transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +39,894
Change %
Price: $0.000000
Shares after: 39,894
Date: 08 Mar 2022
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 39,894
Exercise price
Footnotes: F4, F7

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

Restricted stock units convert into shares of Class A Common Stock on a one-for-one basis.

Footnote F2

Includes 4,552 shares of Class A Common Stock acquired under the Company's 2020 Employee Stock Purchase Plan.

Footnote F3

The option vests as to 25% of the shares on March 8, 2023 and in 12 equal quarterly installments thereafter, such that the option shall be fully vested and exercisable on March 8, 2026.

Footnote F4

Each restricted stock unit represents a contingent right to receive one share of Issuer Class A Common Stock.

Footnote F5

The restricted stock units vest if the Issuer's Class A Common Stock achieves a price per share equal to or greater than $10.00 for any period of thirty (30) consecutive trading days prior to March 8, 2024.

Footnote F6

On March 8, 2021, the Reporting Person was granted 16,288 restricted stock units, vesting in four substantially equal annual installments beginning on March 8, 2022.

Footnote F7

The restricted stock units vest on September 8, 2022, subject to the Reporting Person's continuous employment with the Issuer through such vesting date.